MacroGenics, Inc. (MGNX) NASDAQ

1.75

+0.05(+2.94%)

Updated at February 23 04:00PM

Currency In USD

Valuation

Market Cap203.52M
Enterprise Value58.14M
P/E Ratio-1.46
PEG Ratio0.01
Price/Sales Ratio0.88
Price/Book Ratio1.65
Enterprise/Revenue0.54
Enterprise/EBITDA-1.07

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.6
Operating Margin-0.9

Management Effectiveness

Return On Assets-0.28
Return On Equity-0.98

Income Statement

Revenue148.34M
Revenue/Share1.99
Gross Profit136.04M
EBITDA-57.37M
Net Income-66.97M
Diluted EPS-1.07

Balance Sheet

Total Cash146.4M
Total Cash/Share2.32
Total Debt37.01M
Total Debt/Equity0.55
Current Ratio5.22
Book Value Per Share1.06

Price History

52-Week Change-33.96
52-Week High2.79
52-Week Low0.99
Moving Average 50 Days1.68
Moving Average 200 Days1.6

Statistics

Average Volume1.25M
Shares Outstanding63.26M
% Held by Institutions62.93

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A